Morgan Stanley Starts Cubist Pharmaceuticals (CBST) at Overweight
Tweet Send to a FriendGet Alerts CBST Hot Sheet
Price: $53.48 +8.02%
Rating Summary:
9 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Rating Summary:
9 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Trade CBST Now!
Morgan Stanley initiates coverage on Cubist Pharmaceuticals (NASDAQ: CBST) with a Overweight. PT $68.00.
For an analyst ratings summary and ratings history on Cubist Pharmaceuticals click here. For more ratings news on Cubist Pharmaceuticals click here.
Shares of Cubist Pharmaceuticals closed at $48.48 yesterday, with a 52 week range of $33.43-$49.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Cubist Pharmaceuticals click here. For more ratings news on Cubist Pharmaceuticals click here.
Shares of Cubist Pharmaceuticals closed at $48.48 yesterday, with a 52 week range of $33.43-$49.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cubist Pharmaceuticals (CBST) Spikes to Session Highs
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Wells Fargo Starts Taylor Morrison Home (TMHC) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
